Localization of estrone sulfatase in human breast carcinomas

Breast Cancer

Volumn 6, Issue 4, 1999, Pages 331-337

  Saeki, Toshiaki ^a   Takashima, Shigemitsu ^a   Sasaki, Hiroshi ^b   Hanai, Nobuo ^c   Salomon, David S ^d  

^a Department of Clinical Research and Surgery   (United States)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KYOWA HAKKO KOGYO CO LTD   (Japan)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Breast cancer; Estrone sulfatase; Immunohistochemistry; Western blotting

Indexed keywords

EID: 0003372418     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02966449     Document Type: Review

References (26)

1. Segaloff A: Hormones and mammary carcinogenesis. In: McGuire L ed, Advances in Research and Treatment, Experimentally Biology, Plenum Press, New York, pp1-22, 1978.
2. Prost O, Turrel MO, Dahan N, et al: Estrone and dehydroepiandroeterone sulfatase activity and plasma estrone sulfate levels in human breast carcinoma. Cancer Res 44:661-664, 1984. (Pubitemid 14184601)
3. Pasqualini JR, Chetrite G, Nguyen BL, et al: Estrone sulfate-sulfatase and 17β-hydroxysteroid dehydrogenase activities; A hypothesis for their role in the evolution of human breast cancer from hormonedependence to hormone-indipendence. J Steroid Biochem Mol Biol 53:407-412, 1995.
4. Stein RC, Dowsett M, Hedley A, et al: The clinical and endocrine effects of 4-hydroxyandrostendione alone and in combination with goserelin in premenopausal women with advanced breast cancer. Br J Cancer 62:679-683, 1990. (Pubitemid 20340591)
5. Santen RJ, Santner S, Davis B, et al: Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma. J Clin Endocrinol Metab 47:1257-1265, 1978. (Pubitemid 9091287)
6. Stantner SJ, Feil PD, Santen RJ: In situ estrogen production via estrone sulfatase pathway in breast tumors; Relative importance versus the aromatase pathway. J Clin Endocrinol Metab 59:29-33, 1984. (Pubitemid 14087520)
7. Evans TRJ, Rowlands MG, Law M, et al: Intratumoral oestrone sulpahtase activity as a prognositc marker in human breast carcinoma. Br J Cancer 69:555-561, 1994. (Pubitemid 24076479)
8. Stantner SJ, Wilhelm BO, Santen RJ: Estrone sulfate promotes human breast cancer cell replication and nuclear uptake of estradiol in MCF-7 cell culture. Int J Cancer 54:119-124, 1993. (Pubitemid 23137008)
9. Johnson GR, Saeki T, Auersperg N, et al: Response to and expression of amphiregulin by ovarian carcinoma and normal ovarian surface epithelial cells; Nuclear localization of endogenous amphiregulin. Biochem Biophys Res Commun 180:481-488, 1991.
10. Saeki T, Cristiano A, Lynch MJ, et al: Regulation by estrogen through the 5'-flanking region of the transforming growth factor a gene. Mol Endocrinol 5:1955-1963, 1991.
11. Saeki T, Takahashi T, Okabe M, et al: Immunohistochemical detection of ribonucleotide reductase in human breast tumors. Int J Oncol 6:523-529, 1995.
12. Naitoh K, Honjo H, Yamamoto T, et al: Estrone sulfate and sulfatase activity in human breast cancer and endomerial cancer. J Steroid Biochem 33:1049-1054, 1989. (Pubitemid 20036137)
13. Siiteri P: Adipose tissue as a source of hormones. Am J Clin Nutr 45:277-282, 1987.
14. Fishman J, Nisselbaum JS, Menendez-Botet CJ, et al: Estrone and estradiol content in human breast tumors; Relationship to estradiol receptors. J Steroid Biochem 8:893-896, 1977. (Pubitemid 8163950)
15. Evans TRJ, Rowlands MG, Silvia MC, et al: Intratumoral oestrone sulphatase activity as a prognostic marker in human breast carcinoma; Prognostic significance of aromatase and estrone sulfatase enzymes in human breast cancer. J Steroid Biochem Mol Biol 44:583-587, 1993.
16. Dowsett M, Stein RC, Mehta A, et al: Potency and selectivity of the non-steroidal aromatase inhibitor CGS 16949A in postmenopousal breast cancer patients. Clin Endocrinol 32:623-634, 1990. (Pubitemid 20151459)
17. Di Salle E: Exemestane (FCE24304), a new steroidal aromatase inhibitor. J Steroid Biochem 43:137-143, 1992.
18. Tominaga T, Yoshida Y, Shimozuma K, et al: Effect of CGS 16949A plus Tamoxifen on induced mammary tumors in rat. Eur J Cancer 26:600-603, 1990. (Pubitemid 20259339)
19. Selcer KW, Li PK: Estrogenicity, antiestrogenicity and estrone sulfatase inhibition of estrone-3-amine and estrone-3-thiol. J Steroid Biochem Mol Biol 52:281-286, 1995.
20. Reed MJ, Purohit A, Duncan LJ, et al: The role of cytokines and sulphatase inhibitors in regulating oestrogen synthesis in breast tumours. J Steroid Biochem Mol Biol 53:413-420, 1995.
21. Selcer KW, Hegde PV, Li PK, et al: Inhibition of estrone sulfatase and proliferation of human breast estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal-N-alkanoyl tyramines. Cancer Res 57:702-707, 1997. (Pubitemid 27085654)
22. Chetrite G, Varin C, Delalonde L, et al: Effect of promegestone, tamoxifen, 4-hydroxytamoxifen and ICI 164, 384 on the oestrone sulphatase activity of human breast cancer cells. Anticancer Res 13:931-934, 1993. (Pubitemid 23247440)
23. Pasqualini JR, Maloche C, Maroni M, et al: Effect of the progentage promegestone (R-5020) on mRNA of the oestrone sulphatase in the MCF-7 human mammary cancer cells. Anticancer Res 14:1589-1594, 1994.
24. Utsumi T, Yoshimura N, Takeuchi S, et al: Steroid sulfatase expression is an independent predictor of recurrence in human breast cancer. Cancer Res 59:377-381, 1999 (Pubitemid 29048871)
25. Salomon DS, Dickson RB, Normanno N, et al: Interaction of oncogenes and growth factors in colon and breast cancer. In: Spandidos DA ed, Current Perspectives on Molecular and Cellular Oncology, JAI Press, London, pp211-261, 1992.
26. Fitzpatric S, Brightwell J, Wittliff JL, et al: Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor. Cancer Res 44:3448-3453, 1984. (Pubitemid 14098597)